Related Experiment Videos
Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA class I expression?
P I Schrier1, R Versteeg, L T Peltenburg
1Department of Clinical Oncology, University Hospital Leiden, The Netherlands.
Abstract:
N-ras and c-myc oncogenes were found to be activated in melanoma. High c-myc expression renders melanoma cell lines sensitive to lysis by natural killer (NK) cells. This effect is mediated by locus-specific downmodulation of HLA-B expression by c-myc. Cell lines with a mutation in the N-ras gene were relatively sensitive to NK cells irrespective of HLA class I expression. These findings indicate that NK cells can kill tumor cells with activated myc or ras oncogenes in various ways, thus providing potential mechanisms to eliminate cancer cells with an activation of these oncogenes.
Insights
Natural killer (NK) cells can eliminate melanoma cells with activated N-ras or c-myc oncogenes. This occurs through downmodulation of HLA-B expression by c-myc or via N-ras mutations, offering cancer elimination strategies.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Melanoma is a significant form of skin cancer.
- Oncogenes like N-ras and c-myc play crucial roles in cancer development.
- Natural killer (NK) cells are a critical component of the innate immune system, involved in tumor surveillance.
Purpose of the Study:
- To investigate the role of activated N-ras and c-myc oncogenes in melanoma.
- To determine the susceptibility of melanoma cells with activated oncogenes to NK cell-mediated lysis.
- To elucidate the mechanisms by which NK cells eliminate tumor cells with activated oncogenes.
Main Methods:
- Analysis of N-ras and c-myc oncogene activation in melanoma cell lines.
- Assessment of melanoma cell sensitivity to NK cell lysis.
- Evaluation of HLA-B expression levels in relation to c-myc expression.
- Investigation of NK cell activity in melanoma cell lines with N-ras mutations.
Main Results:
- Activated N-ras and c-myc oncogenes were identified in melanoma.
- High c-myc expression correlated with increased sensitivity to NK cell-mediated lysis.
- c-myc mediated this sensitivity through downmodulation of HLA-B expression.
- Melanoma cell lines with N-ras mutations showed sensitivity to NK cells regardless of HLA class I expression.
Conclusions:
- NK cells possess multifaceted mechanisms to eliminate tumor cells with activated N-ras or c-myc oncogenes.
- Targeting these oncogenes may provide novel therapeutic strategies for melanoma.
- Understanding the interplay between oncogenes and NK cell activity is crucial for cancer immunotherapy.